ArticleMolecular medicine (Cambridge, Mass.)2026
Bispecific antibody AP402 targets p95HER2 and induces costimulation through CD137 to improve efficacy for HER2-positive tumors.
Po-Lin Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.